JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.21, sa.1, ss.63-72, 2008 (SCI-Expanded)
Background. Cyclic intravenous pamidronate treatment is widely used for symptomatic therapy of osteogenesis imperfecta (01). However, data after discontinuation are very limited.